Ipg Photonics CORP

IPG Photonics announced second quarter 2026 financial results, showcasing an 11% year-over-year revenue increase driven by robust Industrial Solutions demand.

IPG Photonics announces a binding offer to acquire Lumibird Medical for $300 million, aiming to expand its medical laser platform and advanced solutions portfolio.

IPG Photonics Corporation shareholders re-elected ten directors and ratified the appointment of Deloitte & Touche LLP at the 2026 Annual Meeting.

IPG Photonics announced first-quarter 2026 financial results, showing a 17% revenue increase driven by Industrial Solutions, and also reported a global settlement of all patent litigation with Trumpf Laser- und Systemtechnik SE.

IPG Photonics announced a German court ruled its AMB lasers infringed a Trumpf patent, impacting less than 1% of total sales.

IPG Photonics announced a Unified Patent Court ruling that certain AMB lasers infringe a Trumpf patent, impacting less than 1% of total sales.

IPG Photonics Corporation announced its second quarter 2026 financial results, showing an 11.1% increase in net sales to $278.6 million, driven by strong performance in Industrial Solutions.

IPG Photonics reports Q1 2026 net sales of $265.5 million and net income of $1.6 million, impacted by a $13.5 million patent litigation settlement.

IPG Photonics reported a significant return to net income in the third quarter and first nine months of 2025, driven by improved gross margins and the absence of prior year's divestiture and impairment charges.

IPG Photonics reported a significant drop in net income and diluted EPS for the second quarter and first half of 2025, driven by lower sales in materials processing and increased operating expenses.

IPG Photonics' Q1 2025 net sales decreased by 9.6% year-over-year to $227.8 million, with a net income of $3.8 million.

IPG Photonics experienced a substantial net loss in the third quarter of 2024, primarily due to the divestiture of its Russian subsidiary and impairment charges related to its Belarusian operations.

IPG Photonics Corporation filed an amendment to its 2025 Annual Report on Form 10-K solely to update the cover page regarding the incorporation by reference of its proxy statement.

IPG Photonics reported a 2.7% revenue increase in 2025 to $1.004 billion, alongside improved gross margins and a return to net income, despite ongoing geopolitical challenges and a patent infringement lawsuit.

IPG Photonics' FY2024 results reveal a revenue decrease, a net loss, and significant leadership changes, including the appointment of a new CEO and the sale of its Russian subsidiary.

IPG Photonics Corporation filed an amendment to its 2023 annual report to include previously omitted information regarding directors, executive compensation, and other corporate governance matters.

IPG Photonics Corporation's 2023 10-K filing reveals a decrease in revenue, strategic shifts in manufacturing, and ongoing efforts to navigate global economic and geopolitical challenges.

Ip Fibre Devices Ltd reported changes in beneficial ownership of Ipg Photonics Corp common stock on July 31, 2026.

Eugene A Scherbakov, a Director and 10% owner of Ipg Photonics Corp, sold 1,524 shares of common stock on July 31, 2026.

Valentin Gapontsev Trust I reported changes in beneficial ownership of Ipg Photonics Corp common stock on July 21, 2026.

IP Fibre Devices Ltd, a 10% owner and director of IPG Photonics Corp, has reported the sale of common stock totaling over 64,000 shares through a Rule 10b5-1 trading plan.

Angelo P. Lopresti, SVP, Secretary & Gen Counsel of IPG Photonics Corp, sold 1,000 shares of common stock for an average price of $110.33 per share, as part of a pre-established trading plan.

IPG Photonics Corp. reports that Eugene A. Scherbakov, a Director and 10% Owner, sold a total of 1,524 shares of common stock on June 29, 2026, under a pre-arranged trading plan.

IPG Photonics achieved 3% revenue growth in 2025, its first since 2021, driven by stabilizing industrial demand and strong execution in medical and advanced applications.

IPG Photonics announces a change in its Nominating and Corporate Governance Committee composition to address shareholder and proxy advisory firm preferences for solely independent directors.

IPG Photonics Corporation has filed a definitive proxy statement with the SEC.

IPG Photonics is seeking stockholder approval for its 2025 Incentive Compensation Plan to replace the 2006 plan and continue offering competitive incentives to employees and directors.

IPG Photonics Corporation has filed a definitive proxy statement with the SEC.

IPG Photonics has scheduled its annual meeting for June 18, 2024, featuring proposals for director elections, executive compensation approval, and auditor ratification.

IPG Photonics Corporation's Schedule 13D filing reveals adjustments in beneficial ownership among key stakeholders, with Eugene A. Shcherbakov now holding 34.3% of the common stock.

Significant beneficial owners of IPG Photonics Corporation, including the Valentin Gapontsev Trusts, have registered 2.15 million shares of common stock for potential resale, which could increase market supply.

IP Fibre Devices (UK) Ltd. has disclosed beneficial ownership of 6,463,302 shares, representing 15.2% of the common stock of IPG Photonics Corporation.

The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in IPG Photonics Corp following an internal realignment.